{"id":8232,"date":"2021-12-16T12:25:51","date_gmt":"2021-12-16T17:25:51","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/abaloparatida-cas-247062-33-5-de-alto-grau-para-reducao-da-taxa-de-fratura-e-incidencia-de-hipercalcemia\/"},"modified":"2021-12-16T12:25:51","modified_gmt":"2021-12-16T17:25:51","slug":"abaloparatida-cas-247062-33-5-de-alto-grau-para-reducao-da-taxa-de-fratura-e-incidencia-de-hipercalcemia","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/pt-br\/product\/abaloparatida-cas-247062-33-5-de-alto-grau-para-reducao-da-taxa-de-fratura-e-incidencia-de-hipercalcemia\/","title":{"rendered":"Abaloparatida CAS 247062-33-5 de alto grau para redu\u00e7\u00e3o da taxa de fratura e incid\u00eancia de hipercalcemia"},"content":{"rendered":"

Abaloparatida CAS 247062-33-5 de alto grau para redu\u00e7\u00e3o da taxa de fratura e incid\u00eancia de hipercalcemia<\/strong><\/h2>\n

Nome do produto: Abaloparatida
\n Sequ\u00eancia: H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu- Arg-Arg-Arg-Glu-Leu-Leu-Glu-Lys-Leu-Leu-N-Me-Ala-Lys- Leu-His-Thr-Ala-NH2
\n Sin\u00f4nimos: Abaloparatida
\n CAS: 247062- 33-5
\n MF: C174H300N56O49
\n MW: 3960.5896
\n EINECS:
\n Categorias de produtos:
\n Arquivo Mol: 247062-33-5.mol <\/p>\n

Abaloparatida, um ativador seletivo do receptor do horm\u00f4nio da paratire\u00f3ide (receptor PTH1), avan\u00e7ou em desenvolvimento cl\u00ednico para o tratamento da osteoporose em mulheres p\u00f3s-menop\u00e1usicas com alto risco de fratura devido \u00e0 sua boa atividade osteog\u00eanica, feita a partir de abaloparatida. <\/p>\n

\u00cdndice t\u00e9cnico de Abaloparatida CAS 247062-33-5<\/strong>
\n Apar\u00eancia: P\u00f3 branco
\n Pureza (HPLC) \u226598,0%
\n Conte\u00fado de acetato 5,0% ~ 12,0%
\n Conte\u00fado de \u00e1gua \u22648,0%
\n Conte\u00fado de pept\u00eddeo\u226580,0%
\n Embalagem e transporte:
\n Baixa temperatura, embalado a v\u00e1cuo, com precis\u00e3o de mg mediante solicita\u00e7\u00e3o. <\/p>\n

Fun\u00e7\u00e3o e aplica\u00e7\u00e3o da abaloparatida CAS 247062-33-5<\/strong>
\n Abaparatida, um pept\u00eddeo que consiste de 34 res\u00edduos de amino\u00e1cidos, \u00e9 um novo pept\u00eddeo relacionado ao horm\u00f4nio da paratire\u00f3ide (PTHrP) desenvolvido pela RadiusHealth, que \u00e9 um ativador poderoso e seletivo do receptor PTH-I para aumentar o conte\u00fado mineral \u00f3sseo, densidade \u00f3ssea e resist\u00eancia \u00f3ssea e promover a forma\u00e7\u00e3o \u00f3ssea , e foi aprovado para comercializa\u00e7\u00e3o pelo FDA em April Chemicalbook 28 de 2017. aprovado para comercializa\u00e7\u00e3o pelo FDA em 28 de abril de 2017 sob o nome comercial Tymlos.Abapatida \u00e9 administrada por via subcut\u00e2nea para o tratamento de osteoporose em mulheres p\u00f3s-menop\u00e1usicas que est\u00e3o em risco de fratura ou que n\u00e3o responderam a outros agentes terap\u00eauticos e \u00e9 eficaz na redu\u00e7\u00e3o da taxa de novas fraturas vertebrais e n\u00e3o vertebrais. A abapatida \u00e9 mais capaz de reduzir as taxas de fratura e hipercalcemia em compara\u00e7\u00e3o com a teriparatida.<\/p>\n","protected":false},"excerpt":{"rendered":"

Nome do produto: Abaloparatida
\n CAS: 247062-33-5
\n MF: C174H300N56O49
\n MW: 3960.5896
\n Arquivo Mol: 247062-33-5.mol<\/p>\n","protected":false},"featured_media":2171,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[],"product_tag":[1417],"class_list":{"0":"post-8232","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_tag-top-grade-abaloparatide-cas-247062-33-5-for-reduced-fracture-rate-and-hypercalcemia-incidence-pt-br","7":"desktop-align-left","8":"tablet-align-left","9":"mobile-align-left","11":"first","12":"instock","13":"shipping-taxable","14":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/pt-br\/wp-json\/wp\/v2\/product\/8232","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/pt-br\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/pt-br\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/pt-br\/wp-json\/wp\/v2\/comments?post=8232"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/pt-br\/wp-json\/wp\/v2\/media\/2171"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/pt-br\/wp-json\/wp\/v2\/media?parent=8232"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/pt-br\/wp-json\/wp\/v2\/product_brand?post=8232"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/pt-br\/wp-json\/wp\/v2\/product_cat?post=8232"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/pt-br\/wp-json\/wp\/v2\/product_tag?post=8232"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}